| 2025 | 2024 | 2023 | 2022 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | 1,8 M € | -25.4% | 2,4 M € | -21.2% | 3,0 M € | -66.9% | 9,2 M € | +43.2% | 6,4 M € | +35.8% | 4,7 M € | -2.9% | 4,9 M € | -19.0% | 6,0 M € | ||||||||
| Gross margin | 535,9 k € | +9.5% | 489,5 k € | +1.9% | 480,6 k € | +5.1% | 457,0 k € | +8.8% | 420,1 k € | +7.5% | 390,6 k € | -26.6% | 531,8 k € | — | — | — | — | — | — | — | — | |||||||||
| EBITDA | 35,8 k € | +8.8% | 32,9 k € | -1.5% | 33,3 k € | +1.2% | 33,0 k € | -17.2% | 39,8 k € | +8.3% | 36,7 k € | -59.7% | 91,1 k € | -22.3% | 117,3 k € | -74.5% | 460,5 k € | +10.4% | 417,1 k € | -55.3% | 933,5 k € | +408.8% | -302,3 k € | -86.7% | -161,9 k € | +11.0% | -181,9 k € | +30.4% | -261,4 k € | |
| Operating profit | 35,8 k € | +8.8% | 32,9 k € | +1.7% | 32,3 k € | +2.6% | 31,5 k € | -20.9% | 39,8 k € | +8.3% | 36,7 k € | -59.7% | 91,1 k € | -22.3% | 117,3 k € | -72.0% | 418,8 k € | +205.9% | 136,9 k € | -78.8% | 644,3 k € | +208.3% | -594,7 k € | -117.1% | -274,0 k € | +16.0% | -326,1 k € | +16.6% | -391,1 k € | |
| Profit/loss | 12,7 k € | +8.1% | 11,8 k € | +65.9% | 7,1 k € | -45.3% | 13,0 k € | -38.9% | 21,2 k € | +2.0% | 20,8 k € | -56.1% | 47,4 k € | -41.9% | 81,7 k € | -72.6% | 298,1 k € | +128.8% | 130,3 k € | -79.4% | 632,2 k € | +180.4% | -786,6 k € | -190.0% | -271,2 k € | +20.0% | -338,9 k € | +15.0% | -398,7 k € | |
| Equity | 167,4 k € | -69.8% | 554,7 k € | +2.2% | 542,9 k € | +1.3% | 535,8 k € | +9.4% | 489,9 k € | +4.5% | 468,6 k € | +4.7% | 447,8 k € | +11.8% | 400,4 k € | +25.6% | 318,7 k € | +131.4% | -1,0 M € | +11.4% | -1,1 M € | +35.6% | -1,8 M € | -79.4% | -990,2 k € | -37.7% | -719,0 k € | -89.1% | -380,1 k € | |
| Total assets | 258,0 k € | -58.0% | 614,0 k € | -1.5% | 623,2 k € | -0.3% | 624,9 k € | +6.3% | 587,8 k € | +0.1% | 587,4 k € | -13.5% | 679,2 k € | -41.1% | 1,2 M € | +91.2% | 603,6 k € | -32.0% | 887,6 k € | -87.2% | 6,9 M € | +16.1% | 6,0 M € | +66.7% | 3,6 M € | +137.0% | 1,5 M € | -29.3% | 2,1 M € | |
| Cash | 105,7 k € | -78.3% | 486,8 k € | -1.0% | 491,9 k € | -1.5% | 499,3 k € | +11.6% | 447,5 k € | -3.7% | 464,5 k € | +4.0% | 446,5 k € | +1.3% | 440,9 k € | +27.2% | 346,6 k € | +3951.9% | 8,6 k € | -88.4% | 74,0 k € | -59.6% | 183,1 k € | -71.0% | 631,9 k € | +19.2% | 530,0 k € | +364.2% | 114,2 k € | |
| Debts | 90,5 k € | +52.6% | 59,3 k € | -26.1% | 80,3 k € | -9.9% | 89,1 k € | -9.0% | 97,9 k € | -17.5% | 118,7 k € | -48.7% | 231,4 k € | -69.2% | 752,5 k € | +170.5% | 278,1 k € | -85.4% | 1,9 M € | -76.5% | 8,1 M € | +4.3% | 7,8 M € | +69.5% | 4,6 M € | +105.0% | 2,2 M € | -11.5% | 2,5 M € | |
| Staff | 3 | 3 | 3 | 3 | 3 | 3,2 | 4,2 | 5,9 | 6,4 | 9 | 18,1 | 28,2 | 20,8 | 24,9 | 24,4 | |||||||||||||||
Private limited company · Machelen (Brab.) · incorporated on 03/12/2007 · 3,0 ETP
Private limited company profitable and well capitalised. Cash position declining (-78.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Accuray Belgium is a Private limited company incorporated in 2007. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Machelen (Brab.). It employs on average 3,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette